Regulatory Affairs
Function
The Committee works on the following issues:
- Downsizing Bureaucracy
- Biosafety Risk Management
- National Tissue Engineering Law
- Stem Cell
- Risk Management Plan
- Advanced Cell Therapies
- European centralised authorisation
Members
Co-ordniator:
Markus Hofbauer, Wacker Biotech GmbH
Experts from the following companies:
Dr. Gabriele Elbl, Wilex AG
Dr. Stefan Fennrich, NMI
Dr. Edgar Fenzl, FGK GmbH
Dr. Irene Gander-Meisterernst, MediGene AG
Ingrid Hanke, PharmaLex
Markus Hofbauer, CellGenix GmbH
Thomas Isenssee, IMTM GmbH
Beatrice Jaha, Celgene GmbH
Dr. Uwe Kramer, FGK GmbH
Dr. Alexandra Martin, Cephalon GmbH
Dr. Rainer Porrmann, Accovion GmbH
Verena Stumpf, MediGene AG
Prof. Dr. Felicia Rosenthal
Prof. Dr. Burkhard Schloßhauer, NMI
Robert Schupp, Celgene GmbH
Dr. Cornelius Sobel, LipoNova AG
Wolfgang Witzel, Life Sciences Group
Dr. Britta Wlotzka, Sirs Lab GmbH